Amendment 2026-0221s to SB400 (2026)

Relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.


Revision: Jan. 22, 2026, 1:44 p.m.

Senate Executive Departments and Administration

January 22, 2026

2026-0221s

12/08

 

 

Amendment to SB 400

 

Amend RSA 126-X:12, IV(a) as inserted by section 1 of the bill by replacing it with the following:

 

(a)  Biannually reviewing medical and scientific evidence pertaining to currently approved and additional qualifying conditions.